These are supplies which include detectnet 1MCI/ML, which is a radioactive diagnostic agent used for positron emission tomography (pet) scans to locate somatostatin receptor-positive neuroendocrine…

Ended Purchase Order Awarded Last action

Contract number
HT001426PE101
Awardee
Awarding agency
Obligated
$177,131

Award facts

Contract value 100% obligated
$177,131.24 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a purchase order to Curium US LLC for $177,131.24 on April 17, 2026, for DetectNet 1MCI/ML, a radioactive diagnostic agent used in positron emission tomography scans to locate somatostatin receptor-positive neuroendocrine tumors. Performance is firm fixed price with place of performance at Bethesda, Maryland. The order concludes on May 1, 2026.

Description

These are supplies which include detectnet 1MCI/ML, which is a radioactive diagnostic agent used for positron emission tomography (pet) scans to locate somatostatin receptor-positive neuroendocrine tumors (nets).

Quick answers

Who was awarded contract HT001426PE101?

HT001426PE101 was awarded to Curium US LLC by Defense Health Agency (Department of Defense) on April 17, 2026.

How much is contract HT001426PE101 worth?

The government has obligated $177,131 on HT001426PE101.

Was contract HT001426PE101 competed?

The extent of competition for HT001426PE101 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award